Investor, Philanthropist, Founder, David E.I. Pyott Foundation
WHY: Longtime Allergan CEO, led company through prevention of hostile takeover by Valeant Pharmaceuticals and Bill Ackman, later sold to Actavis PLC, now Allergan PLC. Earned $543M payout.
RECENT: Serves as chairman, Bioniz Therapeutics, Irvine cancer drugmaker that’s raised $28M to date. Other backers include Masimo’s Joe Kiani.
QUOTABLE: Calls Bioniz “an exciting, emerging biotechnology company with a truly novel approach to addressing autoimmune diseases and cancer.”
